Perlegen Sciences, 454 Life Sciences, Genome Corp., SeqWright, ABI, Affymetrix, Navigenics, Sorenson Molecular Genealogy Foundation, Sorenson Molecular Genealogy Foundation, Nexttec, Deltadot, SAE Consortium, Ceres, Newsham Genetics, ABI, GenomeQuest, Bio | GenomeWeb
Perlegen, 454 Partner in Drug Response Re-sequencing Study
 
Perlegen Sciences and 454 Life Sciences will collaborate on a project to re-sequence “hundreds” of human DNA samples with the goal of developing a test that will predict how patients respond to a certain class of drug, the companies said this week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.